SMSPHARMA — SMS Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
- IN₹17.30bn
- IN₹19.69bn
- IN₹5.22bn
- 56
- 13
- 93
- 56
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,649 | 4,119 | 5,632 | 5,199 | 5,221 |
Cost of Revenue | |||||
Gross Profit | 1,442 | 1,399 | 1,931 | 2,039 | 1,423 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 3,941 | 3,540 | 4,643 | 4,377 | 4,996 |
Operating Profit | 708 | 579 | 988 | 822 | 225 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 624 | 508 | 911 | 685 | 53.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 415 | 327 | 610 | 679 | 38.8 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 400 | 316 | 625 | 622 | -70.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 400 | 316 | 625 | 622 | -70.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.73 | 3.73 | 7.39 | 7.35 | -0.828 |
Dividends per Share |